Peptone Company
We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.
Technology:
Artificial Intelligence, Biotechnology, Pharmaceutical, Quantum Computing
Industry:
AI in Pharma, Early Drug Development, Preclinical Development
Headquarters:
London, England, United Kingdom
Founded Date:
2018-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
7
Total Funding:
42443951
Estimated Revenue:
Less than $1M
Last Funding Date:
2022-06-09
Last Funding Type:
Series A
Register and Claim Ownership